Medicham ex from the EX Emerald expansion currently trades at approximately $75.98 USD for near-mint copies, making it a mid-tier card in the Pokémon TCG market. The card sits at #95 out of 106 in the set as an ultra-rare holo EX Stage 1 Pokémon with 110 HP, and its price reflects steady demand among collectors and players alike. At this price point, it occupies an interesting middle ground—expensive enough to represent a meaningful investment, but not so rare that it commands the premium prices of earlier EX-era cards or chase holos.
The actual price you’ll encounter varies significantly based on condition and where you’re buying. A single card listing on the open market might range anywhere from $29.99 for well-played copies to $200.00 for gem-mint examples, a spread that underscores how critical grading and condition assessment become with EX-era cards. This isn’t a one-price card; understanding that variance is essential before you commit cash.
Table of Contents
- What Determines Medicham ex’s Market Value?
- Condition’s Dramatic Impact on Actual Prices
- Vintage EX Cards as Collectible Assets
- Where to Actually Buy and Pricing Reality
- Grading and the PSA Threshold Problem
- Medicham ex Among Other EX Emerald Holos
- The Long-Term Hold Reality for Mid-Tier EX Cards
What Determines Medicham ex’s Market Value?
The Medicham ex’s price sits squarely in the middle of the EX Emerald set’s pricing tier, influenced by several concrete factors. First, it’s not a highly sought chase card like some of the set’s other holos—cards that are tied to specific competitive metagames or aesthetic appeal tend to command premiums, while solid but unremarkable EX pokémon like Medicham drift toward mid-market pricing. The card has usable text for its era (the Psychic-type weakness and Stage 1 evolution mechanic were relevant in 2004-2005), but it wasn’t a staple of tournament-winning decks the way certain other cards were. Set age and supply matter equally.
EX Emerald was a mainstream large set from 2005, meaning millions of packs were printed. Medicham ex wasn’t a secret rare or charismatic legendary, so supply of the card itself remains reasonable despite its ultra-rare classification. Compare this to a card like Rayquaza ex from the same set—a headline legendary—and you’ll see Rayquaza commands substantially more, often $150+ even in moderate condition. Medicham ex’s accessibility keeps it affordable for newer collectors while still commanding respect as a genuine vintage EX card.
Condition’s Dramatic Impact on Actual Prices
The $75.98 benchmark assumes near-mint condition, a critical detail that separates a legitimate price from overstated ones. Step down to lightly played (minor wear, perhaps a slight corner touch or faint edge wear visible under light), and prices drop into the $40–$60 range on current listings. Move to moderately played (visible but not egregious wear), and you’re looking at the $29.99–$40 bottom end of the market.
This cliff is real and unforgiving. A Medicham ex that spent years in a deck box instead of a sleeve ages faster, accumulates micro-scratches on the holo, and suffers crimp corners that don’t bounce back. Unlike modern cards with protective cases, EX-era holos lived through heavy player use, and the ones still in circulation often show it. If you’re shopping for an example to keep, commit to the higher grade or accept that you’re getting a well-used card at a lower price—but don’t expect a played copy to ever grade high or appreciate significantly.
Vintage EX Cards as Collectible Assets
Medicham ex occupies a specific niche in the broader EX card market that makes it worth understanding. The EX era (roughly 2003–2007) bridges early Pokémon TCG and the game’s modern era, and EX cards from this window have developed a stable collector base. Prices have stabilized over the past few years, moving less volatility than newer products, which is either a feature or a limitation depending on your collecting goals.
If you’re collecting for nostalgia or set completion, Medicham ex’s $75 price is reasonable—it’s the card from a famous set, it’s genuinely rare in high grade, and it represents a moment in Pokémon TCG history. If you’re treating it as a short-term speculative asset, understand that mid-tier EX cards rarely spike in value without external catalysts (a vintage tournament win, renewed competitive interest, or significant PSA/CGC market tightening). The card will likely hold its value but isn’t positioned to double in a year.
Where to Actually Buy and Pricing Reality
TCGPlayer remains the primary marketplace for pricing transparency, and real Medicham ex listings on TCGPlayer show near-mint copies ranging from $65–$85 depending on seller and exact condition descriptor. eBay hosts older stock from estate collections and individual sellers, which can surface deals but requires scrutiny—watch for unrealistic photos, vague condition grading, or sellers unfamiliar with EX-era standards. The spread between asking price and actual sold prices on eBay also tends to be wider than on TCGPlayer’s algorithm-based pricing.
A specific example: a 2024 eBay sale of a lightly played Medicham ex (#95/106) Emerald sold for $52 after bids, while a near-mint copy from a dealer with extensive feedback went for $79. The difference wasn’t just condition—the lower-priced copy had visible holo scratches, while the higher one had sharp corners and minimal wear. Direct retail shops (physical card shops or dedicated online dealers) typically price at or slightly above TCGPlayer, and they’re worth checking if you want immediate availability and a return policy.
Grading and the PSA Threshold Problem
Professional grading—particularly PSA (Professional Sports Authenticator) or CGC—can amplify a Medicham ex’s price significantly or reveal that it’s worth far less than expected. A PSA 8 (near-mint-mint) Medicham ex might fetch $150–$200 from serious collectors, while a PSA 6 (excellent-mint) might reach $100–$120. Below PSA 6, the card enters murky pricing where the grading cost itself ($15–$25) eats into your equity, and you may be better off selling raw.
The critical warning here: do not grade raw cards speculatively. A Medicham ex that looks near-mint to the naked eye might receive a PSA 7 or even a 6 due to factors invisible at arm’s length—holo surface wear, light centering issues, or micro-damage to corners. You’ll have sunk $20–$30 into grading, received a lower grade than you anticipated, and now own a graded copy that’s harder to move than a raw card at the same price tier. Experienced collectors know this trap and typically only slab cards they’ve already identified as high-grade examples.
Medicham ex Among Other EX Emerald Holos
To contextualize Medicham ex’s $75 valuation, compare it to nearby cards in the same set. Rayquaza ex, the set’s apex legendary, typically prices $150–$250 near-mint.
Vileplume ex and Sceptile ex (also strong playable cards) hover around $50–$70. Medicham ex sits comfortably in the upper-mid tier because it’s a recognizable Pokémon with decent stats but not a marquee collector’s piece. If you see Medicham ex priced at $100+ raw and near-mint, the seller is overreaching; $60–$85 is the realistic market window.
The Long-Term Hold Reality for Mid-Tier EX Cards
Medicham ex has appreciated modestly since 2023, moving from roughly $50–$60 to its current $75 range, a 25–50% gain over approximately two years. This reflects broader vintage EX card stabilization rather than explosive demand for Medicham specifically. If you’re holding one, you’ve likely seen modest gains; if you’re considering buying, understand that the card’s upside is capped by its position in the collector hierarchy—it’ll never be the chase card that drives a set’s value.
The practical takeaway: Medicham ex works as either a nostalgia piece for someone who played this era or as a diversified holding in a larger EX card portfolio, but it’s not a lottery ticket. Prices are stable and transparent, the card is available at multiple tiers of condition, and secondary market liquidity is decent. Purchase if the price fits your budget and condition expectations, not because you expect a windfall.
- —
